{'52WeekChange': -0.36426914,
 'SandP52WeekChange': None,
 'address1': '540 Gaither Road',
 'address2': 'Suite 400',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.8,
 'askSize': 1400,
 'averageDailyVolume10Day': 1024387,
 'averageVolume': 596301,
 'averageVolume10days': 1024387,
 'beta': 1.841526,
 'beta3Year': None,
 'bid': 2.8,
 'bidSize': 800,
 'bookValue': 0.389,
 'category': None,
 'circulatingSupply': None,
 'city': 'Rockville',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.86,
 'dayLow': 2.72,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -8.845,
 'enterpriseToRevenue': 23.95,
 'enterpriseValue': 165920720,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 2.6377141,
 'fiftyTwoWeekHigh': 6.19,
 'fiftyTwoWeekLow': 1.52,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 28273600,
 'forwardEps': -0.49,
 'forwardPE': -5.7346935,
 'fromCurrency': None,
 'fullTimeEmployees': 18,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.13822,
 'heldPercentInstitutions': 0.77074,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/cerecor.com',
 'longBusinessSummary': 'Cerecor Inc., a pharmaceutical company, focuses on '
                        'pediatric health care. Its lead product portfolio '
                        'includes prescribed dietary supplements, such as '
                        'Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, '
                        'such as Millipre, Ulesfia, Karbinal ER, AcipHex '
                        'Sprinkle, and Cefaclor for oral suspension, as well '
                        'as Flexichamber a medical device. The company is '
                        'developing CERC-301, an orphan neurological '
                        'indication for controlling neurologic adaptation; '
                        "CERC-406 for the treatment of Parkinson's disease; "
                        'CERC-425, an orally active small molecule; CERC-611, '
                        'a drug candidate for the treatment of partial-onset '
                        'seizures in epilepsy; and CERC-913, a protide '
                        'nucleotide for the treatment of mitochondrial '
                        'disorder. It also developing preclinical therapies '
                        'CERC-801, CERC-802, and CERC-803 for the treatment of '
                        'inherited metabolic disorders. The company was '
                        'formerly known as Ceregen Corporation and changed its '
                        'name to Cerecor Inc. in March 2011. Cerecor Inc. was '
                        'founded in 2011 and is headquartered in Rockville, '
                        'Maryland.',
 'longName': 'Cerecor Inc.',
 'market': 'us_market',
 'marketCap': 213681392,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_145313032',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -33263144,
 'nextFiscalYearEnd': 1640908800,
 'open': 2.73,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '410-522-8707',
 'previousClose': 2.74,
 'priceHint': 4,
 'priceToBook': 7.2236505,
 'priceToSalesTrailing12Months': 30.843838,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.86,
 'regularMarketDayLow': 2.72,
 'regularMarketOpen': 2.73,
 'regularMarketPreviousClose': 2.74,
 'regularMarketPrice': 2.73,
 'regularMarketVolume': 472350,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 74786000,
 'sharesPercentSharesOut': 0.019299999,
 'sharesShort': 1471297,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 465675,
 'shortName': 'Cerecor Inc.',
 'shortPercentOfFloat': 0.0328,
 'shortRatio': 1.81,
 'startDate': None,
 'state': 'MD',
 'strikePrice': None,
 'symbol': 'CERC',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.627,
 'twoHundredDayAverage': 3.0042806,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '55560eef-fab5-3b5e-91ba-1059a52c5225',
 'volume': 472350,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.cerecor.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '20850'}